{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:12:05Z","timestamp":1792685525277,"version":"4.5.0"},"reference-count":220,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Colloid and Interface Science"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cis.2025.103606","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T23:00:04Z","timestamp":1752793204000},"page":"103606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Unveiling the power of polymeric nanoparticles: Pioneering advances in breast cancer treatment"],"prefix":"10.1016","volume":"344","author":[{"given":"Vishal","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurav Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Kesharwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cis.2025.103606_bb0005","doi-asserted-by":"crossref","first-page":"1024143","DOI":"10.3389\/fbioe.2022.1024143","article-title":"Polymeric nanoparticles\u2014promising carriers for cancer therapy","volume":"10","author":"Xiao","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.cis.2025.103606_bb0010","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.3390\/molecules25163731","article-title":"Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology","volume":"25","author":"Zielinska","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.cis.2025.103606_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11070332","article-title":"Anti-angiogenic effect of orally available pemetrexed for metronomic chemotherapy","volume":"11","author":"Maharjan","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cis.2025.103606_bb0020","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6889293","article-title":"Formulation and development of adapalene topical nanohydrogel using different surfactants and cosurfactants for antiacne activity","volume":"2022","author":"Panthi","year":"2022","journal-title":"J Nanomater"},{"key":"10.1016\/j.cis.2025.103606_bb0025","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1080\/10717544.2021.1995077","article-title":"Metronomic delivery of orally available pemetrexed-incorporated colloidal dispersions for boosting tumor-specific immunity","volume":"28","author":"Maharjan","year":"2021","journal-title":"Drug Deliv"},{"key":"10.1016\/j.cis.2025.103606_bb0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ijpharm.2019.05.042","article-title":"Strategizing biodegradable polymeric nanoparticles to cross the biological barriers for cancer targeting","volume":"565","author":"Choudhury","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2025.103606_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.116823","article-title":"A comprehensive review on pharmacokinetic studies of vaccines: impact of delivery route, carrier-and its modulation on immune response","volume":"236","author":"Jha","year":"2023","journal-title":"Environ Res"},{"key":"10.1016\/j.cis.2025.103606_bb0040","first-page":"586","article-title":"Overcoming multidrug resistance of antibiotics via nanodelivery systems","volume":"14","author":"Imran","year":"2022","journal-title":"Pharm"},{"issue":"51","key":"10.1016\/j.cis.2025.103606_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40005-021-00515-1","article-title":"Intestinal membrane transporter-mediated approaches to improve oral drug delivery","volume":"512","author":"Pangeni","year":"2021","journal-title":"J Pharm Investig"},{"key":"10.1016\/j.cis.2025.103606_bb0050","doi-asserted-by":"crossref","DOI":"10.2217\/nnm-2023-0348","article-title":"Futuristic senolytic drug incorporated nanomedicine therapy to treat osteoarthritis","volume":"19","author":"Jha","year":"2024","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.cis.2025.103606_bb0055","series-title":"Polym. nanoparticles as a promis. Tool anti-cancer ther","first-page":"389","article-title":"Conclusion and future prospective of polymeric nanoparticles for cancer therapy","author":"Shukla","year":"2019"},{"key":"10.1016\/j.cis.2025.103606_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112766","article-title":"Polymeric nanoparticles-siRNA as an emerging nano-polyplexes against ovarian cancer","volume":"218","author":"Rehman","year":"2022","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.cis.2025.103606_bb0065","series-title":"Polym. nanoparticles as a promis. Tool anti-cancer ther","first-page":"233","article-title":"Dendrimer-based Nanoparticulate delivery system for cancer therapy","author":"Shukla","year":"2019"},{"key":"10.1016\/j.cis.2025.103606_bb0070","series-title":"Functionalized polymeric nanoparticles for delivery of bioactives, Nanobiomedicine, Publ","first-page":"91","author":"Mishra","year":"2014"},{"key":"10.1016\/j.cis.2025.103606_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/polym15071596","article-title":"Nanoparticles as drug delivery systems: a review of the implication of nanoparticles\u2019 physicochemical properties on responses in biological systems","volume":"15","author":"Yusuf","year":"2023","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.cis.2025.103606_bb0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/jfb10010004","article-title":"Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies","volume":"10","author":"Calzoni","year":"2019","journal-title":"J Funct Biomater"},{"key":"10.1016\/j.cis.2025.103606_bb0085","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jksus.2017.10.004","article-title":"Morphologies and functionalities of polymeric nanocarriers as chemical tools for drug delivery: a review","volume":"31","author":"Venditti","year":"2019","journal-title":"J King Saud Univ - Sci"},{"key":"10.1016\/j.cis.2025.103606_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2023.103470","article-title":"Recent advances in encapsulation techniques for cinnamon bioactive compounds: a review on stability, effectiveness, and potential applications","volume":"57","author":"Culas","year":"2024","journal-title":"Food Biosci"},{"key":"10.1016\/j.cis.2025.103606_bb0095","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3390\/polym15051123","article-title":"Polymeric nanoparticles for delivery of natural bioactive agents: recent advances and challenges","volume":"15","author":"Elmowafy","year":"2023","journal-title":"Polym"},{"key":"10.1016\/j.cis.2025.103606_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17488","article-title":"Advances in drug delivery systems, challenges and future directions","volume":"9","author":"Ezike","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.cis.2025.103606_bb0105","first-page":"2233","article-title":"Recent advances in targeted drug delivery strategy for enhancing oncotherapy","volume":"15","author":"Li","year":"2023","journal-title":"Pharm"},{"key":"10.1016\/j.cis.2025.103606_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nano10071403","article-title":"Polymeric nanoparticles for drug delivery: recent developments and future prospects","volume":"10","author":"Begines","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.cis.2025.103606_bb0115","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1021\/acs.chemrev.5b00135","article-title":"Polymeric nanostructures for imaging and therapy","volume":"115","author":"Elsabahy","year":"2015","journal-title":"Chem Rev"},{"key":"10.1016\/j.cis.2025.103606_bb0120","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.2967\/jnumed.114.146019","article-title":"Theranostic nanoparticles","volume":"55","author":"Chen","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cis.2025.103606_bb0125","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.3390\/nano10101970","article-title":"A review of biodegradable natural polymer-based nanoparticles for drug delivery applications","volume":"10","author":"Idrees","year":"2020","journal-title":"Nanomater"},{"key":"10.1016\/j.cis.2025.103606_bb0130","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2217\/nnm-2017-0011","article-title":"Methotrexate and beta-carotene loaded-lipid polymer hybrid nanoparticles: a preclinical study for breast cancer","volume":"12","author":"Jain","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.cis.2025.103606_bb0135","article-title":"Synthesis, characterization and in vitro assessment of colloidal gold nanoparticles of gemcitabine with natural polysaccharides for treatment of breast cancer","volume":"56","author":"Devi","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.cis.2025.103606_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2022.122000","article-title":"Serum Raman spectroscopy combined with convolutional neural network for rapid diagnosis of HER2-positive and triple-negative breast cancer","volume":"286","author":"Zeng","year":"2023","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"key":"10.1016\/j.cis.2025.103606_bb0145","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1245\/s10434-024-16454-8","article-title":"Prognostic value of the baseline systemic immune-inflammation index in HER2-positive metastatic breast cancer: exploratory analysis of two prospective trials","volume":"32","author":"Pang","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.cis.2025.103606_bb0150","first-page":"1","article-title":"Disulfide bond-driven nanoassembly of lipophilic epirubicin prodrugs for breast cancer therapy","author":"Yuan","year":"2025","journal-title":"J Pharm Investig"},{"key":"10.1016\/j.cis.2025.103606_bb0155","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1586\/era.10.226","article-title":"HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies","volume":"11","author":"Gajria","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.cis.2025.103606_bb0160","article-title":"Recent advances in folic acid engineered nanocarriers for treatment of breast cancer","volume":"56","author":"Tagde","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.cis.2025.103606_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2021.03.011","article-title":"The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer","author":"Singh","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.cis.2025.103606_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120835","article-title":"Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer","volume":"605","author":"Chadar","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2025.103606_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.614290","article-title":"Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy","volume":"11","author":"Bhagwat","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cis.2025.103606_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112530","article-title":"Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer","volume":"146","author":"Sheikh","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cis.2025.103606_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105890","article-title":"Recent advances of dendrimers as multifunctional nano-carriers to combat breast cancer","volume":"164","author":"Dubey","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.cis.2025.103606_bb0190","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jconrel.2021.12.012","article-title":"Chitosan: a versatile bio-platform for breast cancer theranostics","volume":"341","author":"Madamsetty","year":"2021","journal-title":"J Control Release"},{"issue":"5","key":"10.1016\/j.cis.2025.103606_bb0195","doi-asserted-by":"crossref","first-page":"051701","DOI":"10.3788\/COL202018.051701","article-title":"Detection of breast cancer based on novel porous silicon Bragg reflector surface-enhanced Raman spectroscopy-active structure","volume":"18","author":"Wu","year":"2020","journal-title":"Chinese Opt Lett"},{"key":"10.1016\/j.cis.2025.103606_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2023.111898","article-title":"Emerging application of magnetic nanoparticles for breast cancer therapy","volume":"187","author":"Dongsar","year":"2023","journal-title":"Eur Polym J"},{"key":"10.1016\/j.cis.2025.103606_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112441","article-title":"Surface engineered nanocarriers for the management of breast cancer","volume":"130","author":"Nitheesh","year":"2021","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.cis.2025.103606_bb0210","article-title":"A combinatorial delivery of survivin targeted siRNA using cancer selective nanoparticles for triple negative breast cancer therapy","volume":"80","author":"Kesharwani","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.cis.2025.103606_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103353","article-title":"Advancement of cell-penetrating peptides in combating triple-negative breast cancer","volume":"27","author":"Fatima","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.cis.2025.103606_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123276","article-title":"Advancements in dextran-based nanocarriers for treatment and imaging of breast cancer","volume":"643","author":"Khan","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2025.103606_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2022.111781","article-title":"Immunoliposomes as an emerging nanocarrier for breast cancer therapy","volume":"184","author":"Parveen","year":"2023","journal-title":"Eur Polym J"},{"key":"10.1016\/j.cis.2025.103606_bb0230","series-title":"Recent advances in multifunctional dendrimer-based nanoprobes for breast cancer theranostics","first-page":"1","author":"Kesharwani","year":"2022"},{"key":"10.1016\/j.cis.2025.103606_bb0235","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231152083","article-title":"An overview of polymeric nanoparticles-based drug delivery system in cancer treatment","volume":"22","author":"Dristant","year":"2023","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.cis.2025.103606_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19103264","article-title":"Nanoparticle-mediated combination therapy: two-in-one approach for cancer","volume":"19","author":"Gurunathan","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2025.103606_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.116455","article-title":"Targeted therapy of breast tumor by PLGA-based nanostructures: the versatile function in doxorubicin delivery","volume":"233","author":"Sonam Dongsar","year":"2023","journal-title":"Environ Res"},{"key":"10.1016\/j.cis.2025.103606_bb0250","first-page":"2432","article-title":"Advancements in polymeric nanocarriers to mediate targeted therapy against triple-negative breast cancer","volume":"14","author":"Fatima","year":"2022","journal-title":"Pharm"},{"key":"10.1016\/j.cis.2025.103606_bb0255","series-title":"Folic acid engineered sulforaphane loaded microbeads for targeting breast cancer","first-page":"1","author":"Khan","year":"2022"},{"key":"10.1016\/j.cis.2025.103606_bb0260","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/1061186X.2023.2240979","article-title":"Recent advances in novel miRNA mediated approaches for targeting breast cancer","volume":"31","author":"Ahmadi","year":"2023","journal-title":"J Drug Target"},{"key":"10.1016\/j.cis.2025.103606_bb0265","series-title":"Dendrimer as nanocarrier for drug delivery","first-page":"268","volume":"39","author":"Kesharwani","year":"2014"},{"key":"10.1016\/j.cis.2025.103606_bb0270","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.2147\/IJN.S466042","article-title":"Tumor cell-targeting and tumor microenvironment\u2013responsive nanoplatforms for the multimodal imaging-guided photodynamic\/photothermal\/chemodynamic treatment of cervical cancer","volume":"19","author":"Wang","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2025.103606_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.707319","article-title":"Stimuli-responsive polymeric nanoplatforms for cancer therapy","volume":"9","author":"Chang","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.cis.2025.103606_bb0280","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1016\/j.apsb.2022.08.013","article-title":"Smart drug delivery systems for precise cancer therapy","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.cis.2025.103606_bb0285","article-title":"Nano drug delivery system for tumor immunotherapy: next-generation therapeutics","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.cis.2025.103606_bb0290","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bmt.2023.09.001","article-title":"Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment","volume":"5","author":"Elumalai","year":"2024","journal-title":"Biomed Tech"},{"issue":"20","key":"10.1016\/j.cis.2025.103606_bb0295","first-page":"101","article-title":"Engineering precision nanoparticles for drug delivery","volume":"202","author":"Mitchell","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cis.2025.103606_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.610533","article-title":"Tumor microenvironment-stimuli responsive nanoparticles for anticancer therapy","volume":"7","author":"Thomas","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.cis.2025.103606_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25092193","article-title":"Therapeutic nanoparticles and their targeted delivery applications","volume":"25","author":"Yetisgin","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.cis.2025.103606_bb0310","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3390\/polym13071019","article-title":"The effect of poly (ethylene glycol) emulation on the degradation of PLA\/starch composites","volume":"13","author":"Momeni","year":"2021","journal-title":"Polym"},{"key":"10.1016\/j.cis.2025.103606_bb0315","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3390\/jpm11020115","article-title":"HPMA copolymer-based nanomedicines in controlled drug delivery","volume":"11","author":"Chytil","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.cis.2025.103606_bb0320","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3390\/polym14061259","article-title":"Polyacrylic acid nanoplatforms: antimicrobial, tissue engineering, and cancer theranostic applications","volume":"14","author":"Arkaban","year":"2022","journal-title":"Polym"},{"key":"10.1016\/j.cis.2025.103606_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.984311","article-title":"Cyclodextrin nanoparticles for diagnosis and potential cancer therapy: a systematic review","volume":"10","author":"Karthic","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.cis.2025.103606_bb0330","first-page":"433","article-title":"Exploring the application of micellar drug delivery systems in cancer nanomedicine","volume":"16","author":"Wang","year":"2023","journal-title":"Pharm"},{"key":"10.1016\/j.cis.2025.103606_bb0335","doi-asserted-by":"crossref","DOI":"10.1186\/s40824-019-0166-x","article-title":"Therapeutic efficacy of nanoparticles and routes of administration","volume":"23","author":"Chenthamara","year":"2019","journal-title":"Biomater Res"},{"key":"10.1016\/j.cis.2025.103606_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2022.100048","article-title":"Scale-up polymeric-based nanoparticles drug delivery systems: development and challenges","volume":"7","author":"Herdiana","year":"2022","journal-title":"OpenNano"},{"key":"10.1016\/j.cis.2025.103606_bb0345","first-page":"3071","article-title":"Critical evaluation of biodegradable polymers used in nanodrugs","volume":"8","author":"Marin","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2025.103606_bb0350","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.cis.2025.103606_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/nano12030576","article-title":"Exploring various techniques for the chemical and biological synthesis of polymeric nanoparticles","volume":"12","author":"Pulingam","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.cis.2025.103606_bb0360","doi-asserted-by":"crossref","first-page":"1700147","DOI":"10.1002\/smtd.201700147","article-title":"Preparation of particulate polymeric therapeutics for medical applications","volume":"1","author":"Zhuang","year":"2017","journal-title":"Small Methods"},{"key":"10.1016\/j.cis.2025.103606_bb0365","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1515\/ntrev-2016-0050","article-title":"Advanced characterizations of nanoparticles for drug delivery: investigating their properties through the techniques used in their evaluations","volume":"6","author":"Mahmood","year":"2017","journal-title":"Nanotechnol Rev"},{"key":"10.1016\/j.cis.2025.103606_bb0370","first-page":"2561","article-title":"Aptamers as smart ligands for targeted drug delivery in cancer therapy","volume":"14","author":"Wei","year":"2022","journal-title":"Pharm"},{"key":"10.1016\/j.cis.2025.103606_bb0375","first-page":"612","article-title":"Experimental methods for the biological evaluation of nanoparticle-based drug delivery risks","volume":"15","author":"Pandey","year":"2023","journal-title":"Pharm"},{"key":"10.1016\/j.cis.2025.103606_bb0380","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","article-title":"Lipid-based nanoparticles for drug\/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development","volume":"3","author":"Mehta","year":"2023","journal-title":"ACS Mater Au"},{"issue":"25","key":"10.1016\/j.cis.2025.103606_bb0385","first-page":"1","article-title":"Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review","volume":"253","author":"Abbasi","year":"2023","journal-title":"J Nanopart Res"},{"key":"10.1016\/j.cis.2025.103606_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110537","article-title":"Surface functionalized nanoparticles: a boon to biomedical science","volume":"380","author":"Upadhyay","year":"2023","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.cis.2025.103606_bb0395","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.2147\/IJN.S298606","article-title":"A critical review of the use of surfactant-coated nanoparticles in nanomedicine and food nanotechnology","volume":"16","author":"Miyazawa","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2025.103606_bb0400","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1073\/pnas.0909611107","article-title":"DNA aptamer-micelle as an efficient detection\/delivery vehicle toward cancer cells","volume":"107","author":"Wu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cis.2025.103606_bb0405","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1021\/acs.biomac.9b01742","article-title":"Enhancement of loading efficiency by coloading of doxorubicin and quercetin in thermoresponsive polymeric micelles","volume":"21","author":"Soltantabar","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.cis.2025.103606_bb0410","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.addr.2009.01.004","article-title":"Design and development of dendrimer photosensitizer-incorporated polymeric micelles for enhanced photodynamic therapy","volume":"61","author":"Nishiyama","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2025.103606_bb0415","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1039\/C2TB00063F","article-title":"Biocompatible reduction-responsive polypeptide micelles as nanocarriers for enhanced chemotherapy efficacy in vitro","volume":"1","author":"Ding","year":"2012","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.cis.2025.103606_bb0420","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1021\/jo00233a002","article-title":"Starburst polyether dendrimers","volume":"52","author":"Padias","year":"1987","journal-title":"J Org Chem"},{"key":"10.1016\/j.cis.2025.103606_bb0425","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1021\/bc200275g","article-title":"Structurally flexible triethanolamine core pamam dendrimers are effective nanovectors for DNA transfection in vitro and in vivo to the mouse thymus","volume":"22","author":"Liu","year":"2011","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.cis.2025.103606_bb0430","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejpb.2008.09.025","article-title":"Polymersome carriers: from self-assembly to siRNA and protein therapeutics","volume":"71","author":"Christian","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.cis.2025.103606_bb0435","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2008.10.020","article-title":"Polymersome delivery of siRNA and antisense oligonucleotides","volume":"134","author":"Kim","year":"2009","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2025.103606_bb0440","doi-asserted-by":"crossref","first-page":"12816","DOI":"10.1021\/la300874z","article-title":"Targeted polymersome delivery of siRNA induces cell death of breast cancer cells dependent upon orai3 protein expression","volume":"28","author":"Pangburn","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.cis.2025.103606_bb0445","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.addr.2008.08.002","article-title":"Hydrogel nanoparticles in drug delivery","volume":"60","author":"Hamidi","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2025.103606_bb0450","doi-asserted-by":"crossref","first-page":"37","DOI":"10.15212\/bioi-2020-0010","article-title":"Bioactive factors-imprinted scaffold vehicles for promoting bone healing: the potential strategies and the confronted challenges for clinical production","volume":"1","author":"Xue","year":"2020","journal-title":"BIO Integr"},{"key":"10.1016\/j.cis.2025.103606_bb0455","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.addr.2021.02.002","article-title":"Supramolecular engineering of hydrogels for drug delivery","volume":"171","author":"Bernhard","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2025.103606_bb0460","first-page":"1291","article-title":"Polymeric lipid hybrid nanoparticles (PLNs) as emerging drug delivery platform\u2014a comprehensive review of their properties, preparation methods, and therapeutic applications","volume":"13","author":"Sivadasan","year":"2021","journal-title":"Pharm"},{"issue":"3","key":"10.1016\/j.cis.2025.103606_bb0465","first-page":"1","article-title":"pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics","volume":"31","author":"Palanikumar","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/j.cis.2025.103606_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-00863-y","article-title":"Phagocytosis of polymeric nanoparticles aided activation of macrophages to increase atherosclerotic plaques in ApoE\u2212\/\u2212 mice","volume":"19","author":"Yin","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.cis.2025.103606_bb0475","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1039\/D0CS01127D","article-title":"Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine","volume":"50","author":"Sousa De Almeida","year":"2021","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.cis.2025.103606_bb0480","doi-asserted-by":"crossref","first-page":"8267","DOI":"10.1021\/acsnano.0c08596","article-title":"Caveolae-mediated endocytosis drives robust siRNA delivery of polymeric nanoparticles to macrophages","volume":"15","author":"Song","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2025.103606_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100993","article-title":"Revealing macropinocytosis using nanoparticles","volume":"83","author":"Means","year":"2022","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.cis.2025.103606_bb0490","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/10717544.2017.1391889","article-title":"Transporting carriers for intracellular targeting delivery via non-endocytic uptake pathways","volume":"24","author":"Li","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.cis.2025.103606_bb0495","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp800049w","article-title":"Pharmacokinetics and biodistribution of nanoparticles","volume":"5","author":"Li","year":"2008","journal-title":"Mol Pharm"},{"key":"10.1016\/j.cis.2025.103606_bb0500","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jconrel.2007.01.006","article-title":"A multifunctional nano device as non-viral vector for gene delivery: in vitro characteristics and transfection","volume":"118","author":"Gao","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2025.103606_bb0505","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nnano.2012.207","article-title":"Biomolecular coronas provide the biological identity of nanosized materials","volume":"7","author":"Monopoli","year":"2012","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.cis.2025.103606_bb0510","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.addr.2011.03.003","article-title":"Applying macromolecular crowding to enhance extracellular matrix deposition and its remodeling in vitro for tissue engineering and cell-based therapies","volume":"63","author":"Chen","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2025.103606_bb0515","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1021\/acs.chemrev.5b00104","article-title":"Synthesis of L-hexoses","volume":"115","author":"Frihed","year":"2015","journal-title":"Chem Rev"},{"issue":"12","key":"10.1016\/j.cis.2025.103606_bb0520","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"1211","author":"Mura","year":"2013","journal-title":"Nat Mater"},{"key":"10.1016\/j.cis.2025.103606_bb0525","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0168-3659(03)00194-9","article-title":"Biodegradable microspheres for protein delivery","volume":"90","author":"Sinha","year":"2003","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2025.103606_bb0530","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polym"},{"key":"10.1016\/j.cis.2025.103606_bb0535","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2174\/092986706777585077","article-title":"Multidrug resistance: retrospect and prospects in anti-cancer drug treatment","volume":"13","author":"P\u00e9rez-Tom\u00e1s","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.cis.2025.103606_bb0540","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0168-3659(96)01481-2","article-title":"The influence of manufacturing procedure on the degradation of poly(lactide-co-glycolide) 85:15 and 50:50 implants","volume":"43","author":"Ramchandani","year":"1997","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2025.103606_bb0545","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.cis.2025.103606_bb0550","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","article-title":"Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release","volume":"116","author":"Kamaly","year":"2016","journal-title":"Chem Rev"},{"key":"10.1016\/j.cis.2025.103606_bb0560","article-title":"Recent progress and advances in stimuli-responsive polymers for cancer therapy","volume":"6","author":"Vijayakameswara Rao","year":"2018","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.cis.2025.103606_bb0565","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3390\/polym16182606","article-title":"Recent applications of PLGA in drug delivery systems","volume":"16","author":"Yang","year":"2024","journal-title":"Polym"},{"key":"10.1016\/j.cis.2025.103606_bb0570","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/masy.200850313","article-title":"Gamma irradiation effects on mechanical and thermal properties and biodegradation of poly(3-hydroxybutyrate) based films","volume":"263","author":"Hermida","year":"2008","journal-title":"Macromol Symp"},{"key":"10.1016\/j.cis.2025.103606_bb0575","article-title":"Polymeric nanotherapeutics acting at special regions of body","volume":"64","author":"Feczk\u00f3","year":"2021","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.cis.2025.103606_bb0580","doi-asserted-by":"crossref","DOI":"10.5772\/56220","article-title":"Biodegradation of medical purpose polymeric materials and their impact on biocompatibility","author":"Tamariz","year":"2013","journal-title":"Biodegrad - Life Sci"},{"key":"10.1016\/j.cis.2025.103606_bb0585","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1021\/mp100253e","article-title":"PH-responsive nanoparticles for drug delivery","volume":"7","author":"Gao","year":"2010","journal-title":"Mol Pharm"},{"issue":"49","key":"10.1016\/j.cis.2025.103606_bb0590","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40005-019-00439-x","article-title":"Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)\/poly(lactic-co-glycolic acid) micro and nanoparticles","volume":"494","author":"Elmowafy","year":"2019","journal-title":"J Pharm Investig"},{"issue":"Suppl","key":"10.1016\/j.cis.2025.103606_bb0595","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/bcpt.13623","article-title":"Boosting the oral bioavailability of anticancer drugs through intentional drug-drug interactions","volume":"130","author":"Eisenmann","year":"2022","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.cis.2025.103606_bb0600","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.3390\/molecules28248038","article-title":"The bioavailability of drugs\u2014the current state of knowledge","volume":"28","author":"Stielow","year":"2023","journal-title":"Mol"},{"key":"10.1016\/j.cis.2025.103606_bb0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-015-0221-1","article-title":"Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp","volume":"15","author":"Alfarouk","year":"2015","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.cis.2025.103606_bb0610","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/cpt.1211","article-title":"Tumor drug penetration measurements could be the neglected piece of the personalized cancer treatment puzzle","volume":"106","author":"Bartelink","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.cis.2025.103606_bb0615","first-page":"1","article-title":"Breast cancer heterogeneity and its implication in personalized precision therapy","volume":"121","author":"Guo","year":"2023","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.cis.2025.103606_bb0620","doi-asserted-by":"crossref","first-page":"9479","DOI":"10.3390\/app12199479","article-title":"Polymeric nanoparticles\u2014tools in a drug delivery system in selected cancer therapies","volume":"12","author":"Madej","year":"2022","journal-title":"Appl Sci"},{"key":"10.1016\/j.cis.2025.103606_bb0625","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01865-0","article-title":"Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.cis.2025.103606_bb0630","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.3390\/nano12172948","article-title":"Lipid-based nanomaterials for drug delivery systems in breast cancer therapy","volume":"12","author":"Rethi","year":"2022","journal-title":"Nanomater"},{"key":"10.1016\/j.cis.2025.103606_bb0635","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nantod.2014.04.008","article-title":"Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects","volume":"9","author":"Barua","year":"2014","journal-title":"Nano Today"},{"key":"10.1016\/j.cis.2025.103606_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40824-020-0184-8","article-title":"Emerging role of nanosuspensions in drug delivery systems","volume":"24","author":"Jacob","year":"2020","journal-title":"Biomater Res"},{"key":"10.1016\/j.cis.2025.103606_bb0645","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2217\/nnm-2021-0444","article-title":"Treating primary lymphoma of the brain in AIDS patients via multifunctional oral nanoparticulate systems","volume":"17","author":"Jha","year":"2022","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.cis.2025.103606_bb0650","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1080\/10717544.2020.1837293","article-title":"Enhanced oral bioavailability of an etoposide multiple nanoemulsion incorporating a deoxycholic acid derivative-lipid complex","volume":"27","author":"Jha","year":"2020","journal-title":"Drug Deliv"},{"key":"10.1016\/j.cis.2025.103606_bb0655","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jconrel.2020.08.067","article-title":"Enhanced antitumor efficacy of bile acid-lipid complex-anchored docetaxel nanoemulsion via oral metronomic scheduling","volume":"328","author":"Jha","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2025.103606_bb0660","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200004","article-title":"Anti-cancer peptides: classification, mechanism of action, reconstruction and modification","volume":"10","author":"Xie","year":"2020","journal-title":"Open Biol"},{"key":"10.1016\/j.cis.2025.103606_bb0665","doi-asserted-by":"crossref","first-page":"1024143","DOI":"10.3389\/fbioe.2022.1024143","article-title":"Polymeric nanoparticles\u2014promising carriers for cancer therapy","volume":"10","author":"Xiao","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.cis.2025.103606_bb0670","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.cis.2025.103606_bb0675","article-title":"Peptide-functionalized polymeric nanoparticles for delivery of curcumin to cancer cells","volume":"102","author":"Rostami","year":"2024","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.cis.2025.103606_bb0680","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1158\/0008-5472.CAN-13-2015","article-title":"Novel polymeric nanoparticles for intracellular delivery of peptide cargos: antitumor efficacy of the BCL-2 conversion peptide NuBCP-9","volume":"74","author":"Kumar","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.cis.2025.103606_bb0685","doi-asserted-by":"crossref","first-page":"1211603","DOI":"10.3389\/fonc.2023.1211603","article-title":"Recent advances in nanomedicine preparative methods and their therapeutic potential for colorectal cancer: a critical review","volume":"13","author":"Jain","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.cis.2025.103606_bb0690","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2010.05.014","article-title":"A flexible technology for modified-release drugs: multiple-unit pellet system (MUPS)","volume":"147","author":"Abdul","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2025.103606_bb0695","first-page":"775","article-title":"Smart polymeric nanoparticles in cancer immunotherapy","volume":"15","author":"Yu","year":"2023","journal-title":"Pharm"},{"key":"10.1016\/j.cis.2025.103606_bb0700","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1172\/JCI83871","article-title":"Cancer immunotherapy: harnessing the immune system to battle cancer","volume":"125","author":"Yang","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cis.2025.103606_bb0705","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3390\/nano10071403","article-title":"Polymeric nanoparticles for drug delivery: recent developments and future prospects","volume":"10","author":"Begines","year":"2020","journal-title":"Nanomater"},{"key":"10.1016\/j.cis.2025.103606_bb0710","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.3390\/app15063189","article-title":"Enhancement of EPR effect for passive tumor targeting: current status and future perspectives","volume":"15","author":"Vagena","year":"2025","journal-title":"Appl Sci"},{"key":"10.1016\/j.cis.2025.103606_bb0715","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1016\/j.biomaterials.2012.02.041","article-title":"A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery","volume":"33","author":"Liu","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.cis.2025.103606_bb0720","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.610533","article-title":"Tumor microenvironment-stimuli responsive nanoparticles for anticancer therapy","volume":"7","author":"Thomas","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.cis.2025.103606_bb0725","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1039\/C8BM01285G","article-title":"Polymeric micro- and nanoparticles for immune modulation","volume":"7","author":"Ben-Akiva","year":"2018","journal-title":"Biomater Sci"},{"key":"10.1016\/j.cis.2025.103606_bb0730","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1007\/s00262-022-03209-1","article-title":"In vitro and in vivo evaluation of DC-targeting PLGA nanoparticles encapsulating heparanase CD4+ and CD8+ T-cell epitopes for cancer immunotherapy","volume":"71","author":"Tang","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.cis.2025.103606_bb0735","doi-asserted-by":"crossref","first-page":"2209799","DOI":"10.1002\/adma.202209799","article-title":"Biodegradable NIR-II pseudo conjugate polymeric nanoparticles amplify photodynamic immunotherapy via alleviation of tumor hypoxia and tumor-associated macrophage reprogramming","volume":"35","author":"Wan","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.cis.2025.103606_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122655","article-title":"Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapy","volume":"634","author":"Li","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2025.103606_bb0745","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1021\/acsabm.3c00219","article-title":"KCl nanoparticles as potential inducer of immunogenic cell death for cancer immunotherapy","volume":"6","author":"Huang","year":"2023","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.cis.2025.103606_bb0750","doi-asserted-by":"crossref","first-page":"243","DOI":"10.7150\/ntno.65544","article-title":"Anti-PD-L1 F(ab) conjugated PEG-PLGA nanoparticle enhances immune checkpoint therapy","volume":"6","author":"Lee","year":"2021","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.cis.2025.103606_bb0755","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1898105","article-title":"A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma","volume":"10","author":"Slingluff","year":"2021","journal-title":"Oncoimmunology"},{"issue":"17","key":"10.1016\/j.cis.2025.103606_bb0760","first-page":"20","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"171","author":"Shi","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cis.2025.103606_bb0765","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.bcp.2012.01.008","article-title":"Nanoparticle-based combination therapy toward overcoming drug resistance in cancer","volume":"83","author":"Hu","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cis.2025.103606_bb0770","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.addr.2015.12.018","article-title":"Synergistic nanomedicine by combined gene and photothermal therapy","volume":"98","author":"Kim","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2025.103606_bb0775","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.biomaterials.2016.10.053","article-title":"Biomaterials precision combination therapy for triple negative breast cancer via biomimetic polydopamine polymer core-shell nanostructures","volume":"113","author":"Ding","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.cis.2025.103606_bb0780","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2012.03.031","article-title":"Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks","volume":"149","author":"Lee","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.cis.2025.103606_bb0785","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijpharm.2017.07.085","article-title":"Sequential delivery of erlotinib and doxorubicin for enhanced triple negative breast cancer treatment using polymeric nanoparticle","volume":"530","author":"Zhou","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2025.103606_bb0790","series-title":"RSC Advances Polymer grafted magnetic graphene oxide as a potential nanocarrier for pH-responsive delivery of sparingly soluble quercetin against breast cancer cells","first-page":"2574","author":"Matiyani","year":"2022"},{"key":"10.1016\/j.cis.2025.103606_bb0795","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","article-title":"Blood-brain barrier active efflux transporters: ATP-binding cassette gene family","volume":"2","author":"L\u00f6scher","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.cis.2025.103606_bb0800","article-title":"Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer","author":"He","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2025.103606_bb0805","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fphar.2018.00245","article-title":"Editorial: adverse effects of cancer chemotherapy: anything new to improve tolerance and reduce sequelae?","volume":"9","author":"Nurgali","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cis.2025.103606_bb0810","doi-asserted-by":"crossref","first-page":"2200048","DOI":"10.1002\/adma.202200048","article-title":"A transformable amphiphilic and block polymer\u2212dendron conjugate for enhanced tumor penetration and retention with cellular homeostasis perturbation via membrane flow","volume":"34","author":"Gu","year":"2022","journal-title":"Adv Mater"},{"key":"10.1016\/j.cis.2025.103606_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2022.111721","article-title":"Folic acid-poly (N -isopropylacrylamide-maltodextrin) nanohydrogels as novel thermo- \/ pH-responsive polymer for resveratrol breast cancer targeted therapy","volume":"182","author":"Metawea","year":"2023","journal-title":"Eur Polym J"},{"key":"10.1016\/j.cis.2025.103606_bb0820","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202303713","article-title":"Novel vectors and administrations for mRNA delivery","volume":"19","author":"Bai","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.cis.2025.103606_bb0825","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/smll.202304066","article-title":"Lignocellulosic biomass-based carbon dots: synthesis processes, properties, and applications","volume":"19","author":"Gan","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.cis.2025.103606_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2024.133320","article-title":"Colloids and surfaces a\u00a0: physicochemical and engineering aspects one-pot preparation of pH- and redox-responsive polymeric microgel as an efficient carrier for improved breast cancer therapy","volume":"685","author":"Huang","year":"2024","journal-title":"Colloids Surfaces A Physicochem Eng Asp"},{"key":"10.1016\/j.cis.2025.103606_bb0835","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1039\/C7PY01701D","article-title":"Co-delivery of doxorubicin and methotrexate by dendritic chitosan-g-mPEG as a magnetic nanocarrier for multi-drug delivery in combination chemotherapy","volume":"8","author":"Rahimi","year":"2017","journal-title":"Polym Chem"},{"key":"10.1016\/j.cis.2025.103606_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113308","article-title":"Colloids and surfaces B\u00a0: biointerfaces evaluation of methotrexate encapsulated polymeric nanocarrier for breast cancer treatment","volume":"226","author":"Verma","year":"2023","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.cis.2025.103606_bb0845","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.arbres.2017.09.005","article-title":"Esculetin attenuates the growth of lung cancer by downregulating Wnt targeted genes and suppressing NF-\u03baB","volume":"54","author":"Zhu","year":"2018","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.cis.2025.103606_bb0850","series-title":"Journal of Drug Delivery Science and Technology Anti-cancer activity of naringenin loaded smart polymeric nanoparticles in breast cancer","volume":"74","author":"Y\u0131ld\u0131r\u0131m","year":"2022"},{"key":"10.1016\/j.cis.2025.103606_bb0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.338919","article-title":"Label-free triplex DNA-based biosensing of transcription factor using fluorescence resonance energy transfer between N-doped carbon dot and gold nanoparticle","volume":"1181","author":"Mahani","year":"2021","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.cis.2025.103606_bb0860","article-title":"Journal of drug delivery science and technology doxorubicin-loaded polymeric micelles decorated with nitrogen-doped carbon dots for targeted breast cancer therapy","volume":"79","author":"Mahani","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.cis.2025.103606_bb0865","doi-asserted-by":"crossref","first-page":"6556","DOI":"10.21037\/apm-21-1156","article-title":"Oral adverse effects of CDK4\/6 inhibitors among breast cancer patients: a systematic review and meta-analysis","volume":"10","author":"Long","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.cis.2025.103606_bb0870","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s10637-015-0266-y","article-title":"P-glycoprotein and breast cancer resistance protein restrict the brain penetration of the CDK4\/6 inhibitor palbociclib","volume":"33","author":"De Gooijer","year":"2015","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.cis.2025.103606_bb0875","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40265-020-01461-2","article-title":"Inhibiting CDK4\/6 in breast cancer with palbociclib, ribociclib, and abemaciclib: similarities and differences","volume":"81","author":"Braal","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.cis.2025.103606_bb0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123787","article-title":"Targeted delivery and apoptosis induction of CDK-4 \/ 6 inhibitor loaded folic acid decorated lipid-polymer hybrid nanoparticles in breast cancer cells","volume":"651","author":"Rajana","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2025.103606_bb0885","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3892\/ol.2014.2697","article-title":"Nordamnacanthal potentiates the cytotoxic effects of tamoxifen in human breast cancer cells","volume":"9","author":"Subramani","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.cis.2025.103606_bb0890","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drudis.2011.09.009","article-title":"Curcumin nanoformulations: a future nanomedicine for cancer","volume":"17","author":"Yallapu","year":"2012","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.cis.2025.103606_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119583","article-title":"Cytotoxic potential of Artemisia absinthium extract loaded polymeric nanoparticles against breast cancer cells\u00a0: insight into the protein targets","volume":"586","author":"Mughees","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2025.103606_bb0900","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/B978-0-12-814455-8.00009-8","article-title":"Photothermal therapy as emerging combinatorial therapeutic approach","author":"Rajani","year":"2020","journal-title":"Futur Pharm Prod Dev Res"},{"key":"10.1016\/j.cis.2025.103606_bb0905","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2022.08.011","article-title":"Multifunctional graphene oxide nanoparticles for drug delivery in cancer","volume":"350","author":"Itoo","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2025.103606_bb0910","doi-asserted-by":"crossref","first-page":"9243","DOI":"10.1016\/j.actbio.2013.08.016","article-title":"Graphene and graphene oxide as new nanocarriers for drug delivery applications","volume":"9","author":"Liu","year":"2013","journal-title":"Acta Biomater"},{"key":"10.1016\/j.cis.2025.103606_bb0915","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jcis.2022.07.183","article-title":"Surface energetics of graphene oxide and reduced graphene oxide determined by inverse gas chromatographic technique at infinite dilution at room temperature","volume":"628","author":"Lee","year":"2022","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.cis.2025.103606_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213550","article-title":"Biomaterials advances polymeric graphene oxide nanoparticles loaded with doxorubicin for combined photothermal and chemotherapy in triple negative breast cancer","volume":"153","author":"Itoo","year":"2023","journal-title":"Biomater Adv"},{"key":"10.1016\/j.cis.2025.103606_bb0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.jssc.2020.121728","article-title":"\u03b2-Cyclodextrin-functionalized mesocellular silica foams as nanocarriers of doxorubicin","volume":"292","author":"S\u00e1nchez-Orozco","year":"2020","journal-title":"J Solid State Chem"},{"key":"10.1016\/j.cis.2025.103606_bb0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2022.111061","article-title":"Dual anticancer drug delivery of D-galactose-functionalized stimuli-responsive nanogels for targeted therapy of the liver hepatocellular carcinoma","volume":"167","author":"Pooresmaeil","year":"2022","journal-title":"Eur Polym J"},{"key":"10.1016\/j.cis.2025.103606_bb0935","article-title":"Understanding the pH dependent fluorescence and doxorubicin release from graphene oxide functionalized citric acid dendrimer as a highly efficient drug delivery system","volume":"28","author":"Hashemi","year":"2021","journal-title":"Mater Today Commun"},{"key":"10.1016\/j.cis.2025.103606_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2023.111958","article-title":"Construction of a new dual-drug delivery system based on stimuli-responsive co-polymer functionalized D-mannose for chemotherapy of breast cancer","volume":"188","author":"Namazi","year":"2023","journal-title":"Eur Polym J"},{"key":"10.1016\/j.cis.2025.103606_bb0945","doi-asserted-by":"crossref","first-page":"9278","DOI":"10.1039\/C7TB02647A","article-title":"Creation and bioapplications of porous organic polymer materials","volume":"5","author":"Li","year":"2017","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.cis.2025.103606_bb0950","series-title":"Journal of Colloid and Interface Science Facile fabrication of hypercrosslinked microporous polymer nanospheres for effective inhibition of triple negative breast cancer cells proliferation","first-page":"94","volume":"620","author":"Razzaque","year":"2022"},{"key":"10.1016\/j.cis.2025.103606_bb0955","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.addr.2013.11.006","article-title":"Stable RNA nanoparticles as potential new generation drugs for cancer therapy","volume":"66","author":"Shu","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2025.103606_bb0960","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2022.110758","article-title":"Materials & design amphiphilic cationic triblock polymers for p53-mediated triple-negative breast cancer gene therapy","volume":"219","author":"Liu","year":"2022","journal-title":"Mater Des"},{"key":"10.1016\/j.cis.2025.103606_bb0965","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1208\/s12248-016-0003-2","article-title":"Bringing curcumin to the clinic in cancer prevention: a review of strategies to enhance bioavailability and efficacy","volume":"19","author":"Mahran","year":"2017","journal-title":"AAPS J"},{"key":"10.1016\/j.cis.2025.103606_bb0970","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/B978-0-323-46144-3.00014-3","article-title":"Anticancer efficiency of curcumin-loaded invertible polymer micellar nanoassemblies","author":"Hevus","year":"2017","journal-title":"Nanostruct Cancer Ther"},{"key":"10.1016\/j.cis.2025.103606_bb0975","article-title":"Journal of drug delivery science and technology efficient synergistic combination effect of curcumin with piperine by polymeric magnetic nanoparticles for breast cancer treatment","volume":"86","author":"Ahmadi","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.cis.2025.103606_bb0980","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejca.2022.09.031","article-title":"Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis","volume":"177","author":"Viscardi","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cis.2025.103606_bb0985","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104398","article-title":"Irinotecan: 25 years of cancer treatment","volume":"148","author":"Bailly","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cis.2025.103606_bb0990","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15087","article-title":"Heliyon facile construction of irinotecan loaded mesoporous nano-formulation with surface-initiated polymerization to improve stimuli-responsive drug delivery for breast cancer therapy","volume":"9","author":"Nie","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.cis.2025.103606_bb0995","doi-asserted-by":"crossref","first-page":"10019","DOI":"10.1158\/0008-5472.CAN-07-2354","article-title":"Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression","volume":"67","author":"Bunt","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cis.2025.103606_bb1000","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1086862","article-title":"Tumor-intrinsic oncogene pathways mediating immune avoidance","volume":"5","author":"Spranger","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cis.2025.103606_bb1005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.2017.136","article-title":"Hallmarks of response to immune checkpoint blockade","volume":"117","author":"Cogdill","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cis.2025.103606_bb1010","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101884","article-title":"High-dose paclitaxel and its combination with CSF1R inhibitor in polymeric micelles for chemoimmunotherapy of triple negative breast cancer","volume":"51","author":"Lim","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.cis.2025.103606_bb1015","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/smll.201201390","article-title":"Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking","volume":"9","author":"Duan","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.cis.2025.103606_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112305","article-title":"Folate targeted hybrid lipo-polymeric nanoplexes containing docetaxel and miRNA-34a for breast cancer treatment","volume":"128","author":"Sharma","year":"2021","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.cis.2025.103606_bb1025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1207\/s15327914nc5202_11","article-title":"Involvement of c-Jun N-terminal kinase in G2\/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells","volume":"52","author":"Cho","year":"2005","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.cis.2025.103606_bb1030","series-title":"Sulforaphane delivery using mPEG \u2013 PCL co- polymer nanoparticles to breast cancer cells Sulforaphane delivery using mPEG \u2013 PCL co-polymer nanoparticles to breast cancer cells","volume":"7450","author":"Danafar","year":"2016"},{"key":"10.1016\/j.cis.2025.103606_bb1035","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cis.2025.103606_bb1040","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3390\/cancers2021251","article-title":"Exogenous molecular probes for targeted imaging in cancer: focus on multi-modal imaging","volume":"2","author":"Joshi","year":"2010","journal-title":"Cancers"},{"key":"10.1016\/j.cis.2025.103606_bb1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2014.02.022","article-title":"Polymeric nanotheranostics for real-time non-invasive optical imaging of breast cancer progression and drug release","author":"Ferber","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cis.2025.103606_bb1050","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1016\/j.biomaterials.2009.08.008","article-title":"Antiangiogenic properties of silver nanoparticles","volume":"30","author":"Gurunathan","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.cis.2025.103606_bb1055","first-page":"1","article-title":"Core-shell silver \/ polymeric nanoparticles-based combinatorial therapy against breast cancer","author":"Elbaz","year":"2016","journal-title":"Nat Publ Gr"},{"key":"10.1016\/j.cis.2025.103606_bb1060","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cis.2025.103606_bb1065","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.2165\/11538150-000000000-00000","article-title":"Triple-negative breast cancer: epidemiology and management options","volume":"70","author":"Dawood","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.cis.2025.103606_bb1070","series-title":"Nanotheranostics Resveratrol loaded polymeric micelles for theranostic targeting of breast cancer cells","volume":"5","author":"Gregoriou","year":"2021"},{"key":"10.1016\/j.cis.2025.103606_bb1075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1300\/J027v06n02_04","article-title":"How nonprofit organizations can develop comprehensive in-home support services by utilizing various funding streams","volume":"6","author":"Pomeranz","year":"1985","journal-title":"Home Health Care Serv Q"},{"key":"10.1016\/j.cis.2025.103606_bb1080","series-title":"Comparison, synthesis and evaluation of anticancer drug-loaded polymeric nanoparticles on breast cancer cell lines Comparison, synthesis and evaluation of anticancer drug-loaded polymeric nanoparticles on breast cancer cell lines","volume":"1401","author":"Journal","year":"2016"},{"key":"10.1016\/j.cis.2025.103606_bb1085","doi-asserted-by":"crossref","DOI":"10.1186\/2001-1326-1-29","article-title":"Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer","volume":"1","author":"Seto","year":"2012","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.cis.2025.103606_bb1090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5173(00)00617-7","article-title":"Solubilization of rapamycin","volume":"213","author":"Simamora","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2025.103606_bb1095","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1038\/sj.onc.1206948","article-title":"P-glycoprotein: from genomics to mechanism","volume":"22","author":"Ambudkar","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.cis.2025.103606_bb1100","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-2006-957450","article-title":"Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers","volume":"64","author":"Shoba","year":"1998","journal-title":"Planta Med"},{"key":"10.1016\/j.cis.2025.103606_bb1105","series-title":"Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment","volume":"7544","author":"Katiyar","year":"2016"}],"container-title":["Advances in Colloid and Interface Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001868625002179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001868625002179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T20:28:19Z","timestamp":1755808099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001868625002179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":220,"alternative-id":["S0001868625002179"],"URL":"https:\/\/doi.org\/10.1016\/j.cis.2025.103606","relation":{},"ISSN":["0001-8686"],"issn-type":[{"value":"0001-8686","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling the power of polymeric nanoparticles: Pioneering advances in breast cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Advances in Colloid and Interface Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cis.2025.103606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103606"}}